Characterization and Evaluation of Detoxification Functions of a Nontumorigenic Immortalized Porcine Hepatocyte Cell Line (HepLiu)
Open Access
- 1 May 1999
- journal article
- research article
- Published by SAGE Publications in Cell Transplantation
- Vol. 8 (3) , 219-232
- https://doi.org/10.1177/096368979900800301
Abstract
Primary porcine hepatocytes (PPH) are currently used in research and therapeutic applications as the biological component of extracorporeal liver assist devices to overcome the shortage of human hepatocytes. However, their finite life span and typically rapid loss of functions limit their utility. An immortalized, nontumorigenic, highly differentiated porcine hepatocyte cell line was developed in our laboratory to resolve these disadvantages. PPH were transfected with simian virus 40 (SV40) T antigen under the control of the SV40 early promoter. From the established 69 clones, 23 clones displaying hepatocyte-like morphology were screened for diazepam metabolism. One clone, HepLiu D63, has been maintained in culture for > 2 years, through more than 60 passages and 240 divisions. Albumin protein, present in early passages, was lost at later passages, but albumin transcript still was detectable in later passages. Carbamoyl phosphate synthetase, a gateway enzyme of the urea cycle, was consistently detectable in HepLiu cells. Cytokeratin 18, a characteristic marker of primary hepatocytes, was detected by both immunofluorescent staining and Western blot in HepLiu cells. Furthermore, maintenance of P450 functions in HepLiu cells was evidenced by diazepam and 7-ethoxycoumarin metabolites measured by HPLC. Phase II conjugative function was measured as acetaminophen glucuronidation. P450 dealkylase was demonstrated microscopically by the conversion of a nonfluorescent substrate to a fluorescent product. Both Northern blot analysis and immunofluorescent staining showed SV40 T antigen expression in the nuclei of HepLiu cells. No tumor formation occurred when HepLiu cells were injected into severe combined immunodeficient (SCID) mice nor was the TA1 (a tumor marker) mRNA expressed, even in later passages. This immortalized, nontumorigenic, highly functional cell line may provide a valuable tool for drug/toxicological studies, liver biologic regulation studies, and artificial liver support systems.Keywords
This publication has 44 references indexed in Scilit:
- Call for moratorium on xenotransplantsNature, 1998
- Early Clinical Experience with a Hybrid Bioartificial LiverScandinavian Journal of Gastroenterology, 1995
- Initiation of autoimmunity to the p53 tumor suppressor protein by complexes of p53 and SV40 large T antigen.The Journal of Experimental Medicine, 1994
- Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.Genes & Development, 1992
- SV40 Large T Inhibits Myogenic Differentiation Partially through Inducing c-junThe Journal of Biochemistry, 1992
- Characterization of human cytochrome P450 enzymesThe FASEB Journal, 1992
- MINIREVIEW: Differentiated Mammalian Cell Lines Immortalized by Temperature Sensitive Tumor VirusesMolecular Endocrinology, 1989
- SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility geneCell, 1988
- Support of cultured hepatocytes by a laminin-rich gel. Evidence for a functionally significant subendothelial matrix in normal rat liver.Journal of Clinical Investigation, 1987
- Prolonged Maintenance of Active Cytochrome P-450 in Adult Rat Hepatocytes Co-Cultured with Another Liver Cell TypeHepatology, 1984